SPRO (Spero Therapeutics, Inc. Common Stock) Stock Analysis - SEC Filings

Spero Therapeutics, Inc. Common Stock (SPRO) is a publicly traded Healthcare sector company. As of May 21, 2026, SPRO trades at $2.63 with a market cap of $149.39M and a P/E ratio of 0.00. SPRO moved +1.16% today. Year to date, SPRO is +8.23%; over the trailing twelve months it is +286.65%. Its 52-week range spans $0.51 to $3.22. Rallies surfaces SPRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find SPRO SEC filings?

Rallies organizes SPRO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

SPRO Key Metrics

Key financial metrics for SPRO
MetricValue
Price$2.63
Market Cap$149.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$3.22
52-Week Low$0.51
Volume1.08K
Avg Volume0
Revenue (TTM)$13.51M
Net Income$-525.95K
Gross Margin57.80%

Latest SPRO News

Recent SPRO Insider Trades

  • Rajavelu Esther sold 25.24K (~$63.35K) on May 4, 2026.
  • Rajavelu Esther sold 37.10K (~$87.56K) on Feb 6, 2026.
  • Rajavelu Esther sold 50.82K (~$119.93K) on Feb 6, 2026.

SPRO Analyst Consensus

SPRO analyst coverage data. Average price target: $0.00.

Common questions about SPRO

Where can I find SPRO SEC filings?
Rallies organizes SPRO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show SPRO 10-K and 10-Q filings?
Rallies organizes SPRO SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is SPRO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SPRO. It does not provide personalized investment advice.
SPRO

SPRO